Mar 28, 10:05 a.m., New York
Create my watchlists and portfolios login | register
Nektar Therapeutics US6402681083

Nektar Therapeutics Posting Substantial Gain In Afternoon Trading

03/20/17

WASHINGTON (dpa-AFX) - Shares of Nektar Therapeutics (NKTR) continue to see significant strength in afternoon trading on Monday, with the biopharmaceutical company surging up by 37 percent. Nektar has reached its highest intraday level in well over ten years.

Advertisement

The jump by Nektar comes after the company announced positive results from a study of its new opioid pain medication.

Copyright RTT News/dpa-AFX


                                                                                                                        

Make newratings better! What can newratings do better?